Results 61 to 70 of about 8,726 (121)

血浆D-二聚体定量检测对慢性乙型肝炎患者的临床意义

open access: yesZhongguo shiyan zhenduanxue, 2015
慢性乙型肝炎患者常伴有的多种出凝血异常及病情加剧导致的弥散性血管内凝血,都是与血浆中的凝血因子(clotting factors)有关[1,2]。而作为凝血因子之一的D-二聚体是纤维蛋白溶解循环的分子标记物,目前已被作为一个临床诊断依据,这是因为D-二聚体是交联纤维蛋白降解产物中的最小片段,为继发性纤溶的特有代谢物[3,4]。本文通过检测214例不同程度的乙型肝炎患者血浆D-二聚体 ...
谢淑红, 卓传尚, 柳丽娟
doaj  

重度子痫前期实验室指标的检测和临床意义

open access: yesZhongguo shiyan zhenduanxue, 2013
子痫前期是妊娠期高血压疾病的一种,严重威胁母婴健康。近年研究表明妊娠期高血压疾病的发生可能是凝血与抗凝、纤溶机制的改变,血小板激活和血管壁内皮细胞损伤共同作用的结果,使妊娠期高血压疾病患者处于高凝或血栓前状态[1]。本文通过观察和对比重度子痫前期、正常晚期妊娠和非妊娠女性的凝血及血小板指标,揭示它们的变化与重度子痫前期的关系,并探讨其临床意义。
翟宏, 续薇
doaj  

[Consensus of Chinese experts on diagnosis and treatment of disseminated intravascular coagulation in obstetrics]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Thrombosis and Hemostasis Group   +2 more
europepmc   +1 more source

[Correlation of anti-phosphatidylserine/prothrombin antibodies with unexplained recurrent miscarriages]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2023
Yao ZQ   +7 more
europepmc   +1 more source

多发伤患者凝血状态变化的研究

open access: yesZhongguo shiyan zhenduanxue, 2006
目的探讨多发伤患者的凝血、抗凝、纤溶系统的状况及其临床意义。方法检测了41例多发伤患者伤后24 h内及伤后第3 d,30例正常健康人血液中部分凝血因子、抗凝、纤溶活性和血小板计数,根据创伤严重程度分为脏器功能不全组(n=18)与脏器功能正常组(n=23),将24 h内的各检测指标进行比较分析;以及根据预后分为死亡组(n=12)与非死亡组(n=29)的24 h内各检测指标与第3 d的结果比较。结果多发伤各组24 h内纤维蛋白原(FIB)、凝血因子Ⅷ活性(FⅧ:C)、血管性血友病因子(vWF)、血浆D ...
于晓燕   +4 more
doaj  

[Establishment and validation of a risk prediction model for disseminated intravascular coagulation patients with electrical burns]. [PDF]

open access: yesZhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi, 2023
Li Q   +7 more
europepmc   +1 more source

[Construction of an Early-stage Risk Prediction Model for Trauma-Induced Coagulopathy]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban
Xu X   +7 more
europepmc   +1 more source

[Visual analysis of the current research status and development of burn-related coagulation dysfunction]. [PDF]

open access: yesZhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi, 2023
Ma QM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy